Tozorakimab

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AsthmaChronic Obstructive Pulmonary DiseaseChronic Bronchitis

1050 competitors in Asthma

#DrugCompanyPhaseTrials

1

Veramyst

GSK

Preclinical

462

Xolair

Roche

Preclinical

253

Tozorakimab

AstraZeneca

Phase 3

14

Singulair

AstraZeneca

Preclinical

175

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

306

Celexa

AbbVie

Preclinical

17

Atrovent

Boehringer Ingelheim

Preclinical

58

Aciphex

Akero Therapeutics

Preclinical

29

Atrovent

Boehringer Ingelheim

Preclinical

210

Tylenol

KKenvue Brands

Preclinical

1Show 9 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Chronic Obstructive Pulmonary Disease4 trials

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.

Active, not recruiting·AstraZeneca·Phase 3·NCT05158387·1,172 enrolled

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Active, not recruiting·AstraZeneca·Phase 3·NCT05166889·1,132 enrolled

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Active, not recruiting·AstraZeneca·Phase 3·NCT06040086·1,454 enrolled

Show 1 more trial

A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils

Active, not recruiting·AstraZeneca·Phase 2·NCT06897748·98 enrolled

Chronic Bronchitis1 trial

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis

Completed·AstraZeneca·Phase 2·NCT04631016·137 enrolled

ESS1 trial

An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab

Completed·AstraZeneca·Phase 1·NCT06908577·254 enrolled

Efficacy and Safety1 trial

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Recruiting·AstraZeneca·Phase 3·NCT05624450·2,870 enrolled

Age1 trial

A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers

Completed·AstraZeneca·Phase 1·NCT06304961·46 enrolled

1 more indication

Asthma1 trial

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Recruiting·AstraZeneca·Phase 2·NCT06932263·540 enrolled

Details

Drug Info

Related News